Login
Super Investors SOPHROSYNE CAPITAL LLC
SC

SOPHROSYNE CAPITAL LLC

Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.

Portfolio value
$11.5M
Positions
8
Quarter ended
September 30, 2015
Filed
November 13, 2015

Reported portfolio value by quarter (10 quarters reported)

$151M $11.5M
Q2 13 Q4 13 Q2 14 Q4 14 Q2 15 Q3 15

$128M in Q2 2013 → $11.5M now. Hover for any quarter.

Holdings

As reported for the quarter ended September 30, 2015. Activity is the change in share count since the prior quarter's filing.

Holding % of portfolio Activity Shares Value
Ciena Corp 69.8% New 388,527 $8.05M
P Purecycle Corp 25.2% Unchanged 587,026 $2.91M
Cadiz Inc 1.9% Trimmed 71% 29,500 $214K
Aerovironment Inc 1.0% Unchanged 6,000 $120K
O Opower Inc 0.9% Added 208% 12,000 $107K
Balchem Corp 0.5% Trimmed 18% 900 $55K
Limoneira Co 0.4% Unchanged 3,000 $50K
Darling Ingredients Inc 0.3% Unchanged 2,700 $30K

Timeline of changes

What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.

Q3 2015

quarter ended September 30, 2015 · filed November 13, 2015

Company Action Shares changed Value of change % of portfolio
Ciena Corp New +388,527 +$8.05M 69.8%
Biotelemetry Inc Exited −432,853 −$4.08M —
Iradimed Corp Exited −68,751 −$1.6M —
M Meetme Inc Exited −650,000 −$1.11M —
HI Health Ins Innovations Inc Exited −209,925 −$1.04M —
Axogen Inc Exited −237,266 −$745K —
Cadiz Inc Trimmed −71,689 −$520K 1.9%
E Envivio Inc Exited −234,852 −$446K —
O Opower Inc Added +8,100 +$72.2K 0.9%
Calavo Growers Inc Exited −600 −$31K —

Showing the 10 largest of 12 changes.

Q2 2015

quarter ended June 30, 2015 · filed August 14, 2015

Company Action Shares changed Value of change % of portfolio
Iradimed Corp Trimmed −270,407 −$6.29M 12.0%
ZA Zeltiq Aesthetics Inc Exited −146,097 −$4.51M —
M Microstrategy Inc Exited −24,600 −$4.16M —
Biotelemetry Inc Trimmed −394,451 −$3.72M 30.6%
PN Procera Networks Inc Exited −226,806 −$2.13M —
RN Rentech Nitrogen Partners L Exited −131,900 −$1.99M —
CS Cardiovascular Sys Inc Del Exited −48,400 −$1.89M —
R Rentech Inc Exited −1,612,003 −$1.81M —
Silicom Ltd Exited −43,200 −$1.78M —
UN Ubiquiti Networks Inc Exited −60,000 −$1.77M —

Showing the 10 largest of 34 changes.

Q1 2015

quarter ended March 31, 2015 · filed April 20, 2015

Company Action Shares changed Value of change % of portfolio
C Cynosure Inc Exited −89,700 −$2.46M —
Biotelemetry Inc Trimmed −224,838 −$1.99M 12.6%
RN Rentech Nitrogen Partners L Added +119,200 +$1.79M 3.4%
ZA Zeltiq Aesthetics Inc Trimmed −46,500 −$1.43M 7.7%
CS Cardiovascular Sys Inc Del Trimmed −36,700 −$1.43M 3.2%
BS Biodelivery Sciences Intl In Trimmed −124,500 −$1.3M 1.6%
UN Ubiquiti Networks Inc Added +31,600 +$933K 3.0%
P Purecycle Corp Trimmed −180,594 −$910K 5.5%
P Pharmathene Inc Exited −500,000 −$903K —
PM Pandora Media Inc Exited −41,100 −$734K —

Showing the 10 largest of 44 changes.

Q4 2014

quarter ended December 31, 2014 · filed January 26, 2015

Company Action Shares changed Value of change % of portfolio
ZA Zeltiq Aesthetics Inc Trimmed −191,821 −$5.36M 8.3%
M Microstrategy Inc Trimmed −17,638 −$2.87M 6.8%
A Alcobra Ltd Exited −159,826 −$2.47M —
PT Pain Therapeutics Inc Exited −581,762 −$2.27M —
Durect Corp Exited −1,202,112 −$1.77M —
O Ovascience Inc Trimmed −38,200 −$1.69M 1.2%
MI Mfc Indl Ltd Exited −213,500 −$1.52M —
Liveperson Inc Exited −115,500 −$1.45M —
K Kofax Ltd Exited −160,400 −$1.24M —
S&W Seed Co Exited −263,941 −$1.12M —

Showing the 10 largest of 56 changes.

Q3 2014

quarter ended September 30, 2014 · filed November 14, 2014

Company Action Shares changed Value of change % of portfolio
BS Biodelivery Sciences Intl In Trimmed −203,100 −$3.47M 3.9%
Iradimed Corp New +378,771 +$2.66M 3.1%
A Alcobra Ltd Trimmed −143,750 −$2.22M 2.9%
PG Priceline Grp Inc Exited −1,400 −$1.68M —
CP Catalyst Pharm Partners Inc Exited −600,000 −$1.52M —
Liveperson Inc New +115,500 +$1.45M 1.7%
PT Pain Therapeutics Inc Trimmed −369,600 −$1.44M 2.7%
C Cynosure Inc New +67,000 +$1.41M 1.7%
Accuray Inc Exited −141,500 −$1.25M —
P Purecycle Corp Added +170,148 +$1.1M 6.2%

Showing the 10 largest of 68 changes.

Q2 2014

quarter ended June 30, 2014 · filed August 14, 2014

Company Action Shares changed Value of change % of portfolio
SA Syngenta Ag Exited −80,050 −$6.05M —
N1 Net 1 Ueps Technologies Inc Exited −381,490 −$3.8M —
AP Acelrx Pharmaceuticals Inc Exited −248,976 −$2.99M —
Durect Corp New +1,269,019 +$2.31M 2.4%
R Rentech Inc Added +746,427 +$1.93M 2.7%
PG Priceline Grp Inc New +1,400 +$1.68M 1.7%
Cutera Inc Exited −139,689 −$1.56M —
BS Biodelivery Sciences Intl In Trimmed −122,386 −$1.48M 4.9%
CS Cardiovascular Sys Inc Del Added +46,300 +$1.44M 3.0%
DT Durata Therapeutics Inc Exited −105,500 −$1.42M —

Showing the 10 largest of 83 changes.

Q1 2014

quarter ended March 31, 2014 · filed May 14, 2014

Company Action Shares changed Value of change % of portfolio
Biotelemetry Inc New +1,098,174 +$11.1M 9.7%
Biotelemetry Inc Exited −1,231,718 −$9.78M —
Calix Inc Exited −639,165 −$6.16M —
SA Syngenta Ag Added +78,700 +$5.95M 5.3%
HI Health Ins Innovations Inc New +449,845 +$4.65M 4.1%
Accuray Inc Exited −529,500 −$4.61M —
N1 Net 1 Ueps Technologies Inc Trimmed −324,976 −$3.24M 3.3%
Durect Corp Exited −1,813,971 −$3.14M —
Accuray Inc New +258,300 +$2.48M 2.2%
ZA Zeltiq Aesthetics Inc Trimmed −120,900 −$2.37M 6.7%

Showing the 10 largest of 96 changes.

Q4 2013

quarter ended December 31, 2013 · filed February 13, 2014

Company Action Shares changed Value of change % of portfolio
Aerovironment Inc Trimmed −164,226 −$4.8M 0.1%
BS Biodelivery Sciences Intl In Trimmed −779,944 −$4.59M 3.6%
Siga Technologies Inc Exited −1,167,185 −$4.46M —
PT Pain Therapeutics Inc Added +849,206 +$4.13M 5.4%
A Alcobra Ltd Added +204,626 +$3.68M 5.1%
S&W Seed Co Trimmed −483,136 −$3.35M 0.4%
UN Ubiquiti Networks Inc Trimmed −68,600 −$3.15M 1.7%
Calix Inc Trimmed −318,641 −$3.07M 5.4%
M Microstrategy Inc Trimmed −23,000 −$2.86M 6.5%
NP Novabay Pharmaceuticals Inc Exited −1,608,452 −$2.77M —

Showing the 10 largest of 84 changes.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support